Most Recent
EY may seek damages against rival consulting firm Alvarez & Marsal after it won preliminary discovery to pursue possible claims over a mass departure of partners and staff from its international tax practice.
Construction PRO
The Port Authority of NSW has won its claim for public interest immunity over six cabinet documents in a suit by a defunct sand importer over a lease agreement for a mulit-user facility at Glebe Island, with a judge finding they had little forensic value.
Construction PRO
A court has ordered a stay of proceedings in a Melbourne property dispute, saying whether it could hear the case "better" than VCAT, as alleged by builder Brocon, was not the point.
Gold exploration company Zuleika Gold has to produce a draft technical report to Vango Mining as it seeks "significant damages' over a repudiated joint venture agreement, with a judge finding an affidavit from its solicitor put the report squarely in issue.
Construction PRO
A construction company working on accommodation for Rio Tinto FIFO workers has won its bid to set aside a $1 million creditor’s demand by a subcontractor, with a judge finding the demand was an abuse of process.
Jetstar is seeking an initial trial on an issue it claims will be a “silver bullet” against a class action on behalf of hundreds of thousands of customers whose flights were cancelled during the COVID-19 pandemic.
Construction PRO
The operator of a gym previously inside a Bankstown RSL club has scored a partial win on appeal against its new landlord, but has only received nominal damages of $10.
Construction PRO
A judge has allowed Charter Hall to respond to developer Pro-Invest’s expert evidence in a case claiming $100 million in damages for the lost opportunity to build a 26-storey hotel in the Sydney CBD.
Construction PRO
An appeals court has declined to revive a negligence case against a solicitor accused by a former client of failing to advise him on key clauses in a rescinded $1.7 million sale contract.
Mayne Pharma has said it may seek to shut out US drug maker Cosette's expert evidence in proceedings over the purported termination of their $672 million merger.